Abstract

EFFICACY OF VIRECANA KARMA (TRIVṚT CURNA) FOLLOWED BY UROVASTI (KṢĪRABALA TAILA) IN THE MANAGEMENT OF UCCA RAKTACĀPA WITH SPECIAL REFERENCE TO STAGE I ESSENTIAL HYPERTENSION

S. Supraja* and K. Harshavardhana Appaji

.

Abstract

Essential hypertension remains significant global health burden, necessitating exploration of alternative therapeutic modalities. In Ayurveda, there is no direct reference regarding this disease which completely resembles with hypertension. R.R.Desai, correlated hypertension with Ucca Raktacāpa. Essential hypertension was screened in light of Vata–Pitta Pradhana Rakta Pradoshaja Vikara as mentioned by Acarya Caraka. This clinical study aimed to assess the efficacy of Virecana and Urovasti in managing the Stage I Essential hypertension. A total of 30 participants diagnosed with Stage I Essential hypertension were subjected to Virecana and Urovasti. The primary outcome measure was the reduction in systolic and diastolic blood pressure levels. Additionally, improvements in lipid profile and quality of life were noted with no significant adverse events reported. Both Virecana and Urovasti demonstrated significant reductions in blood pressure levels. These findings suggest that Virecana and Urovasti hold promise as effective adjunctive therapies for essential hypertension management.

Keywords: Virecana, Urovasti, Ucca Raktac?pa, Essential hypertension.